GSK GSK stock has risen 16.9% year to date compared with an increase of 7.0% for the industry. The stock has also ...

The inclusion of cancer in the new research partnership suggests GSK's continuing interest in the therapy area, despite its divestment of its marketed oncology portfolio to Novartis. Being first ...

In this article, we are going to take a look at where GSK plc (NYSE:GSK ... a wide range of companies that provide patient care, research and development of new medicines, and design, manufacture ...

Every year, amid Women’s History Month, March 8 marks International Women’s Day—a day dedicated to both honoring past efforts ...

UK drugmaker GSK is struggling to convince the market that ... particularly in speciality medicines and in areas like oncology.” The drugmaker does not have one potential mega blockbuster ...

In a report released today, Emily Field from Barclays maintained a Hold rating on GlaxoSmithKline (GSK – Research Report), with a price target ...